Riskpilot← Back to searchSign inGet full accessEDGE HEALTH TECH AS
ASActiveOrg 925568120Lagerveien 9, 4033 StavangerEngineering activities and related technical consultancy · NACE 7112Est. 20200 employees
Revenue 2024
NOK 0
EBITDA margin
—
-2051% vs 2023
Equity ratio
—
Financial strength
Net profit 2024
NOK -51K
-2073% vs 2023
| Revenue | NOK 0 | — |
| EBITDA | NOK -51K | -2051% |
| Net profit | NOK -51K | -2073% |
| Total assets | NOK 0 | -100% |
| Equity | NOK -25K | -198% |
| Employees | 0 | — |
Legal name
EDGE HEALTH TECH AS
Org number
925568120
Legal form
Aksjeselskap
NACE code
7112 · Engineering activities and related technical consultancy
Founded
11. november 2020
Share capital
NOK 30 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
To styremedlemmer i fellesskap. Daglig leder alene.
Company purpose
Drive verdiskapning gjennom å utvikle teknologi som kan assistere helsepersonell i å redde liv, muliggjøre behandling av pasienter og forbedre tjenester som blir levert.
Address
Lagerveien 9, 4033 Stavanger
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | −0 | −0 | −0 | −0 | −0 |
| EBITDA | 0 | −10 | −2 | −2 | −51 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | 0 | −10 | −2 | −2 | −51 |
| Net financials | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | 0 | −10 | −2 | −2 | −51 |
| Tax | 0 | −0 | −0 | −0 | −0 |
| Net profit | 0 | −10 | −2 | −2 | −51 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 40 | 30 | 28 | 26 | 0 |
| Equity | 40 | 30 | 28 | 26 | −25 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 0 | 0 | 0 | 0 | 25 |
| Total debt | 0 | 0 | 0 | 0 | 25 |
EBITDA margin
-5055700.0%
This company
15.8%
Market median
-31998201% vs market
20202024
Equity ratio
-2500000.0%
This company
38.2%
Market median
-6544603% vs market
20202024
Return on equity
-5055700.0%
This company
18.4%
Market median
-27476730% vs market
20202024
Net profit margin
-5055700.0%
This company
8.1%
Market median
-62416149% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
1.00×
This company
0.62×
Market median
-61% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
ES Chief Executive Officer | Chief Executive Officer | 2020 |
SF Deputy Member | Deputy Member | 2020 |
| Former (1) | ||
SD Deputy Member | Deputy Member | 2020 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2020 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 60% | 60% | 2022 | |
| Company | 40% | 40% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Lux Aeterna Invest As
EDGE HEALTH TECH AS Board members of EDGE HEALTH TECH AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Eivind Sivertsen Gransæther | Chief Executive Officer | 0 companies |
| Soledad Ducasson Farladansky | Deputy Member | 0 companies |
| Soledad Farladansky Gransæther | Deputy Member | 0 companies |
| Asbjørn Stokka | Chairman | 0 companies |